Imagine a small device, like a digital thermometer, that can 'smell' chemicals in your breath to tell if you are getting sick before you even feel it. It uses a tiny chip to analyze breath markers that signal a lung attack is coming. This lets patients get treatment at home instead of rushing to the emergency room.
COPD exacerbations are currently diagnosed based on symptoms, which often happens too late, leading to high hospitalization and mortality rates.
A functional plasma-generating microchip and a working prototype system for controlled breath analysis testing.
If you are a medical device company dealing with the lack of home-monitoring tools for lung disease — this project developed a handheld breathalyzer that can prevent up to 95% of hospitalizations.
If you are a digital health provider dealing with delayed diagnosis of COPD exacerbations — this project developed a digital biomarker-based monitoring solution that enables timely prediction and treatment.
If you are a clinic network dealing with high readmission rates for COPD patients — this project developed a non-invasive breath analysis tool that shifts care from symptom-based reaction to preventive monitoring.
Based on available project data, the specific unit cost or market price is not mentioned.
The project has developed a functional plasma-generating microchip using planar technology, which is typically suitable for industrial scaling.
Based on available project data, specific licensing terms are not provided, but the technology is developed by a consortium including RespiQ and SINTEF.
The project period runs from 2023-11-01 to 2027-04-30, suggesting the technology is currently in the development and validation phase.
The consortium is working with clinical COPD specialists from KCL to validate a transformative clinical workflow for at-home monitoring.
The consortium is well-balanced for a hardware-to-clinic transition, featuring a 40% industry ratio with 2 SMEs. It combines deep technical expertise in microchips (RespiQ, SINTEF) and electrical engineering (uRoboptics) with clinical validation from high-tier institutions like KCL and LUMC across 4 countries.
Contact Academisch Ziekenhuis Leiden for partnership inquiries.
Contact us to explore licensing opportunities for plasma emission spectroscopy sensors.
